Key facts about our PI products:
AASTON is continuously controlled by the German authorities and is observing relevant EU Guidelines (GDP and GMP).
The German legislator has recognized the positive effects of PI products for the German health system and has established an import quota system to support the use of PI products.
AASTON uses European price differences in order to offer its products at lower reimbursement prices than the original. PI products are up to 15% cheaper.
Production of pharmaceuticals is no longer restricted by national borders. Few production sites supply several national markets. AASTON simply parallel imports!
AASTON adapts its products according to mandatory German labeling requirements using validated processes only. We pay high attention to labeling quality to ensure easy market access.
AASTON sources from a network of trusted and reliable suppliers that are themselves supervised by their local authorities.